Feras Jirjees1, Muna Barakat2, Qamar Shubbar3, Bayan Othman2, Hamzah Alzubaidi3, Hala Al-Obaidi4. 1. College of Pharmacy, University of Sharjah, UAE. Electronic address: fjirjees@sharjah.ac.ae. 2. School of Pharmacy, Applied Science Private University, Jordan. 3. College of Pharmacy, University of Sharjah, UAE. 4. College of Pharmacy and Health Sciences, Ajman University, UAE.
Abstract
BACKGROUP: the widespread COVID-19 infection worldwide has resulted in the inability of healthcare facilities to receive all infected patients; therefore, most are treated at home. In addition, factors such as high mortality, types and severity of symptoms, and the prevalence of unreliable information have prompted patients to resort to self-treatment. OBJECTIVES: To assess prevention, treatment, degree of symptoms, and sources of information among patients with COVID-19 in Arab countries METHOD: A cross-sectional study was conducted in seven Arab countries: Algeria, Egypt, Iraq, Lebanon, Libya, Tunisia, and the United Arab of Emirates. People who have recovered from COVID-19 completed the study questionnaire. Score of symptoms during and after COVID-19 infection has been calculated by giving the participants a list of 13 symptoms. RESULTS: A total of 3519 participants completed the survey. Mostly females (68.3%), and aged between 18 and 40 years old (59.4%). Prophylaxis treatments, including vaccines and antibiotics, have been used in around 40% of the participants. The total average score of symptoms during the infection period was found 7.31 ± 3.66 out of 13. However, the symptoms score upon recovery was low (0.48 ± 1.11 score). The significant associations with increased incidence of symptoms during infection were reported with older people, married, divorced or widowed, people with chronic diseases, and obese. Moreover, significant associations with decreased symptoms were reported with those who worked in the health sector, non- or ex-smokers, and vaccinated people. CONCLUSION: The use of medication and other treatments to prevent infection with COVID-19 was common among the participants in the seven countries. Taking the vaccine was the only effect on the number of symptoms experienced by patients. Although nearly two years have passed since the onset of the disease, there is still a need to raise treatment awareness among patients at home.
BACKGROUP: the widespread COVID-19 infection worldwide has resulted in the inability of healthcare facilities to receive all infected patients; therefore, most are treated at home. In addition, factors such as high mortality, types and severity of symptoms, and the prevalence of unreliable information have prompted patients to resort to self-treatment. OBJECTIVES: To assess prevention, treatment, degree of symptoms, and sources of information among patients with COVID-19 in Arab countries METHOD: A cross-sectional study was conducted in seven Arab countries: Algeria, Egypt, Iraq, Lebanon, Libya, Tunisia, and the United Arab of Emirates. People who have recovered from COVID-19 completed the study questionnaire. Score of symptoms during and after COVID-19 infection has been calculated by giving the participants a list of 13 symptoms. RESULTS: A total of 3519 participants completed the survey. Mostly females (68.3%), and aged between 18 and 40 years old (59.4%). Prophylaxis treatments, including vaccines and antibiotics, have been used in around 40% of the participants. The total average score of symptoms during the infection period was found 7.31 ± 3.66 out of 13. However, the symptoms score upon recovery was low (0.48 ± 1.11 score). The significant associations with increased incidence of symptoms during infection were reported with older people, married, divorced or widowed, people with chronic diseases, and obese. Moreover, significant associations with decreased symptoms were reported with those who worked in the health sector, non- or ex-smokers, and vaccinated people. CONCLUSION: The use of medication and other treatments to prevent infection with COVID-19 was common among the participants in the seven countries. Taking the vaccine was the only effect on the number of symptoms experienced by patients. Although nearly two years have passed since the onset of the disease, there is still a need to raise treatment awareness among patients at home.
Authors: Dominic L Sykes; Luke Holdsworth; Nadia Jawad; Pumali Gunasekera; Alyn H Morice; Michael G Crooks Journal: Lung Date: 2021-02-11 Impact factor: 3.777
Authors: Arnold J Sadio; Fifonsi A Gbeasor-Komlanvi; Rodion Y Konu; Akila W Bakoubayi; Martin K Tchankoni; Alexandra M Bitty-Anderson; Iris M Gomez; Claudia P Denadou; Joël Anani; Harold R Kouanfack; Innocent K Kpeto; Mounerou Salou; Didier K Ekouevi Journal: BMC Public Health Date: 2021-01-06 Impact factor: 3.295
Authors: Jessica J Bartoszko; Reed A C Siemieniuk; Elena Kum; Anila Qasim; Dena Zeraatkar; Long Ge; Mi Ah Han; Behnam Sadeghirad; Arnav Agarwal; Thomas Agoritsas; Derek K Chu; Rachel Couban; Andrea J Darzi; Tahira Devji; Maryam Ghadimi; Kimia Honarmand; Ariel Izcovich; Assem Khamis; Francois Lamontagne; Mark Loeb; Maura Marcucci; Shelley L McLeod; Sharhzad Motaghi; Srinivas Murthy; Reem A Mustafa; John D Neary; Hector Pardo-Hernandez; Gabriel Rada; Bram Rochwerg; Charlotte Switzer; Britta Tendal; Lehana Thabane; Per O Vandvik; Robin W M Vernooij; Andrés Viteri-García; Ying Wang; Liang Yao; Zhikang Ye; Gordon H Guyatt; Romina Brignardello-Petersen Journal: BMJ Date: 2021-04-26
Authors: Jeanine P D Guidry; Linnea I Laestadius; Emily K Vraga; Carrie A Miller; Paul B Perrin; Candace W Burton; Mark Ryan; Bernard F Fuemmeler; Kellie E Carlyle Journal: Am J Infect Control Date: 2020-11-20 Impact factor: 2.918